Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Willger SD, Grim SL, Dolben EL, Shipunova A, Hampton TH, et al. 2014. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome, 2(1), p.40.

  View at Publisher | View at Google Scholar

• Rabin HR and Surette MG, 2012. The cystic fibrosis airway microbiome. Current opinion in pulmonary medicine, 18(6), pp.622-627.

  View at Publisher | View at Google Scholar

• Liu J, Wu C, Huang IH, Merritt J and Qi F, 2011. Differential response of Streptococcus mutans towards friend and foe in mixed-species cultures. Microbiology, 157(9), pp.2433-2444.

  View at Publisher | View at Google Scholar

• Zemanick ET, Wagner BD, Robertson CE, Stevens MJ, Szefler SJ, et al. 2015. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. Annals of the American Thoracic Society, 12(2), pp.221-229.

  View at Publisher | View at Google Scholar

• Sibley CD, Church DL, Surette MG, Dowd SE and Parkins MD, 2012. Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: microbial constituents of empyema, liver abscess, and intracerebral abscess. European journal of clinical microbiology & infectious diseases, 31(10), pp.2679-2691.

  View at Publisher | View at Google Scholar

• Olson AB, Sibley CD, Schmidt L, Wilcox MA, Surette MG, et al. 2010. Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes. Journal of clinical microbiology, 48(4), pp.1150-1160.

  View at Publisher | View at Google Scholar

• Mossialos D and Amoutzias GD, 2009. Role of siderophores in cystic fibrosis pathogenesis: Foes or friends?. International Journal of Medical Microbiology, 299(2), pp.87-98.

  View at Publisher | View at Google Scholar

• Kuznetsov V, Lee HK, Maurer-Stroh S, Molnár MJ, Pongor S, et al. 2013. How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health. Health Information Science and Systems, 1(1), p.2.

  View at Publisher | View at Google Scholar

• Hélène M, Estelle JB and Anne-Laure M, 2012. Atypical bacteria in the CF airways: diversity, clinical consequences, emergence and adaptation. INTECH Open Access Publisher.

  View at Publisher | View at Google Scholar

• Baldan R, Cigana C, Testa F, Bianconi I, De Simone M, et al. 2014. Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection. PLoS One, 9(3), p.e89614.

  View at Publisher | View at Google Scholar

• Flume PA, 2011. Pneumothorax in cystic fibrosis. Current opinion in pulmonary medicine, 17(4), pp.220-225.

  View at Publisher | View at Google Scholar

• Lopes SP, Azevedo NF and Pereira MO, 2015. Microbiome in cystic fibrosis: shaping polymicrobial interactions for advances in antibiotic therapy. Critical reviews in microbiology, 41(3), pp.353-365.

  View at Publisher | View at Google Scholar

• Dennersten U, Lannefors L, Höglund P, Hellberg K, Johansson H, et al. 2009. Lung function in the aging Swedish cystic fibrosis population. Respiratory medicine, 103(7), pp.1076-1082.

  View at Publisher | View at Google Scholar

• Dickson RP, Erb-Downward JR and Huffnagle GB, 2015. Homeostasis and its disruption in the lung microbiome. American Journal of Physiology-Lung Cellular and Molecular Physiology, 309(10), pp.L1047-L1055.

  View at Publisher | View at Google Scholar

• Payne MS, Goss KC, Connett GJ, Legg JP, Bruce KD, et al. 2012. A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia. Journal of clinical microbiology, 50(3), pp.909-914.

  View at Publisher | View at Google Scholar

• Michon AL, Jumas-Bilak E, Chiron R, Lamy B and Marchandin H, 2014. Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients. PloS one, 9(2), p.e90164.

  View at Publisher | View at Google Scholar

• Sato Y, Civiello M, Bell SC, Willis BL and Bourne DG, 2016. Integrated approach to understanding the onset and pathogenesis of black band disease in corals. Environmental microbiology.

  View at Publisher | View at Google Scholar

• Dalhoff A, 2014. Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. Clinical microbiology reviews, 27(4), pp.753-782.

  View at Publisher | View at Google Scholar

• Rejzek M, Kannathasan VS, Wing C, Preston A, Westman EL, et al. 2009. Chemical synthesis of UDP-Glc-2, 3-diNAcA, a key intermediate in cell surface polysaccharide biosynthesis in the human respiratory pathogens B. pertussis and P. aeruginosa. Organic & biomolecular chemistry, 7(6), pp.1203-1210.

  View at Publisher | View at Google Scholar

• Magalhães AP, Azevedo NF, Pereira MO and Lopes SP, 2016. The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy. Applied microbiology and biotechnology, 100(3), pp.1163-1181.

  View at Publisher | View at Google Scholar

• McNeely D, Moore JE, Elborn JS, Millar BC, Rendall J, et al. 2009. Isolation of Burkholderia cenocepacia and Burkholderia vietnamiensis from human sewage. International journal of environmental health research, 19(2), pp.157-162.

  View at Publisher | View at Google Scholar

• Sibley CD, Grinwis ME, Rabin HR and Surette MG, 2010. Azithromycin paradox in the treatment of cystic fibrosis airway disease. Future microbiology, 5(9), pp.1315-1319.

  View at Publisher | View at Google Scholar

• Kaur J, Pethani BP, Kumar S, Kim M, Sunna A, et al. 2015. Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients.

  View at Publisher | View at Google Scholar

• Goldberg JB, 2010. Emergence of Pseudomonas aeruginosa in cystic fibrosis lung infections. In Pseudomonas (pp. 141-175). Springer Netherlands.

  View at Publisher | View at Google Scholar

• Lopes SP, Carvalho DT, Pereira MO and Azevedo NF, 2017. Discriminating between typical and atypical cystic fibrosis-related bacterial species by multiplex PNA-FISH. Biotechnology and Bioengineering, 114(2), pp.355-376.

  View at Publisher | View at Google Scholar

• Cribbs SK and Beck JM, 2017. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease. Translational Research, 179, pp.84-96.

  View at Publisher | View at Google Scholar

• Johnson EJ, Zemanick ET, Accurso FJ, Wagner BD, Robertson CE, et al. 2016. Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis. PloS one, 11(1), p.e0147643.

  View at Publisher | View at Google Scholar

• Dharmaprakash A, Thandavarayan R, Joseph I and Thomas S, 2015. Development of broad-spectrum antibiofilm drugs: strategies and challenges. Future microbiology, 10(6), pp.1035-1048.

  View at Publisher | View at Google Scholar

• Thornton CS, Brown EL, Alcantara J, Rabin HR and Parkins MD, 2015. Prevalence and impact of S treptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC pulmonary medicine, 15(1), p.49.

  View at Publisher | View at Google Scholar

• Winward C, Sackley C, Metha Z, Rothwell PM (2009) A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke 40: 757-761.

  View at Publisher | View at Google Scholar

• Ormstad H, Aass HC, Amthor KF, Lund-Sørensen N, Sandvik L (2011) Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. Journal of neurology 258: 670-676.

  View at Publisher | View at Google Scholar

• White JH, Gray KR, Magin P, Attia J, Sturm J,et al. (2012) Exploring the experience of post-stroke fatigue in community dwelling stroke survivors: a prospective qualitative study. Disability and rehabilitation 34: 1376-1384.

  View at Publisher | View at Google Scholar

• Kutlubaev MA, Duncan FH, Mead GE (2012) Biological correlates of post‐stroke fatigue: a systematic review. Acta Neurologica Scandinavica 125: 219-227.

  View at Publisher | View at Google Scholar

• Eilertsen G, Ormstad H, Kirkevold M (2013) Experiences of poststroke fatigue: qualitative meta‐synthesis. Journal of advanced nursing 69: 514-525.

  View at Publisher | View at Google Scholar

• Morris G, Berk M, Galecki P, Walder K, Maes M (2016) The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. Molecular neurobiology 53: 1195-1219.

  View at Publisher | View at Google Scholar

• Chestnut TJ (2011) Fatigue in stroke rehabilitation patients: a pilot study. Physiotherapy Research International 16: 151-158.

  View at Publisher | View at Google Scholar

• Zedlitz AM (2013) Brittle Brain Power. Post-stroke fatigue, explorations into assessment and treatment 2013.

  View at Publisher | View at Google Scholar

• Liu X, Kenkare K, Li S, Desai V, Wong J, et al. () Increased Th17/Treg ratio in poststroke fatigue. Mediators of inflammation 2015.

  View at Publisher | View at Google Scholar

• Liu CH, Tsai CH, Li TC, Yang YW, Huang WS, et al. (2016) Effects of the traditional Chinese herb Astragalus membranaceus in patients with poststroke fatigue: A double-blind, randomized, controlled preliminary study. Journal of Ethnopharmacology 194:954-962.

  View at Publisher | View at Google Scholar

• Vinicuk C, Pintosh E (2016) Early rehabilitation after acute ischemic disorders of cerebral circulation. International neurological journal 8: 86.

  View at Publisher | View at Google Scholar

• Vinychuk SM, Fartushna OY (2016) Early Rehabilitation after Acute Ischemic Cerebrovascular Events. INTERNATIONAL NEUROLOGICAL JOURNAL 8: 34-39.

  View at Publisher | View at Google Scholar

• Thornton CS, Brown EL, Alcantara J, Rabin HR and Parkins MD, 2015. Prevalence and impact of S treptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC pulmonary medicine, 15(1), p.49.

  View at Publisher | View at Google Scholar

• Vinychuk SM Fartushny OE (2016) Early rehabilitation after acute ischemic cerebrovascular events. International Neurology Journal 8: 34-39.

  View at Publisher | View at Google Scholar

• Lo JB, Appel LE, Herbig SM, McCray SB, Thombre AG (2009) Formulation design and pharmaceutical development of a novel controlled release form of azithromycin for single-dose therapy. Drug development and industrial pharmacy 35: 1522-1529.

  View at Publisher | View at Google Scholar

• Keravec M, Mounier J, Prestat E, Vallet S, Jansson JK, et al. 2015. Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization. SpringerPlus, 4(1), p.405.

  View at Publisher | View at Google Scholar

• Blondeau JM (2006) Update on the use of the macrolides for community-acquired respiratory tract infections.

  View at Publisher | View at Google Scholar

• Heirali A, McKeon S, Purighalla S, Storey DG, Rossi L, et al. 2016. Assessment of the microbial constituents of the home environment of individuals with cystic fibrosis (CF) and their association with lower airways infections. PloS one, 11(2), p.e0148534.

  View at Publisher | View at Google Scholar

• Ormerod KL, George NM, Fraser JA, Wainwright C and Hugenholtz P, 2015. Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients. PeerJ, 3, p.e1223.

  View at Publisher | View at Google Scholar

• Jankovic J, Stacy M (2007) Medical management of levodopa-associated motor complications in patients with Parkinson’s disease. CNS drugs 21: 677-692.

  View at Publisher | View at Google Scholar

• Thornton CS, Grinwis ME, Sibley CD, Parkins MD, Rabin HR, et al. 2015. Antibiotic susceptibility and molecular mechanisms of macrolide resistance in streptococci isolated from adult cystic fibrosis patients. Journal of Medical Microbiology, 64(11), pp.1375-1386.

  View at Publisher | View at Google Scholar

Relevant Topics